Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2025-11-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$186.6m reported value +32.7% vs Q2 2025
38positions
64.1%in top 10
3 new 0 added 3 reduced 3 sold out vs Q2 2025

Holdings, Q3 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 5,475,516 $28.6m15.32% 15.32% UnchangedShares held: Q4 2024 5.5m, Q1 2025 5.5m, Q2 2025 5.5m, Q3 2025 5.5m
2 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 895,269 $13.4m7.20% 7.20% UnchangedShares held: Q4 2024 760.4k, Q1 2025 830.9k, Q2 2025 895.3k, Q3 2025 895.3k
3 SPDR GOLD TR GOLD SHS GLD GLD 32,000 $11.4m6.10% 6.10% UnchangedShares held: Q4 2024 32.0k, Q1 2025 32.0k, Q2 2025 32.0k, Q3 2025 32.0k
4 ENTERA BIO LTD SHS ENTX ENTX 5,881,879 $11.3m6.05% 6.05% UnchangedShares held: Q4 2024 5.9m, Q1 2025 5.9m, Q2 2025 5.9m, Q3 2025 5.9m
5 MEIRAGTX HLDGS PLC COM MGTX MGTX 1,250,000 $10.3m5.51% 5.51% UnchangedShares held: Q4 2024 1.2m, Q1 2025 1.2m, Q2 2025 1.2m, Q3 2025 1.2m
6 KINROSS GOLD CORP COM KGC KGC 410,000 $10.2m5.46% 5.46% ReducedShares held: Q4 2024 440.0k, Q1 2025 440.0k, Q2 2025 440.0k, Q3 2025 410.0k -30.0k -30,000 -6.8%
7 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 600,000 $9.2m4.91% 4.91% UnchangedShares held: Q4 2024 600.0k, Q1 2025 600.0k, Q2 2025 600.0k, Q3 2025 600.0k
8 AGNICO EAGLE MINES LTD COM AEM AEM 52,750 $8.9m4.76% 4.76% ReducedShares held: Q4 2024 55.5k, Q1 2025 55.5k, Q2 2025 55.5k, Q3 2025 52.8k -2.8k -2,750 -5.0%
9 SANDSTORM GOLD LTD COM NEW SSL SSL 700,000 $8.8m4.70% 4.70% UnchangedShares held: Q4 2024 0, Q1 2025 700.0k, Q2 2025 700.0k, Q3 2025 700.0k
10 SEABRIDGE GOLD INC COM COM 317,003 $7.7m4.10% 4.10% UnchangedShares held: Q4 2024 317.0k, Q1 2025 317.0k, Q2 2025 317.0k, Q3 2025 317.0k
11 OCULAR THERAPEUTIX INC COM OCUL OCUL 600,400 $7.0m3.76% 3.76% UnchangedShares held: Q4 2024 600.4k, Q1 2025 600.4k, Q2 2025 600.4k, Q3 2025 600.4k
12 ELICIO THERAPEUTICS INC COM ELTX ELTX 630,915 $6.9m3.70% 3.70% UnchangedShares held: Q4 2024 0, Q1 2025 630.9k, Q2 2025 630.9k, Q3 2025 630.9k
13 FRANCO NEV CORP COM FNV FNV 25,000 $5.6m2.99% 2.99% UnchangedShares held: Q4 2024 25.0k, Q1 2025 25.0k, Q2 2025 25.0k, Q3 2025 25.0k
14 NUVATION BIO INC COM CL A NUVB NUVB 1,025,000 $5.5m2.97% 2.97% UnchangedShares held: Q4 2024 0, Q1 2025 1.0m, Q2 2025 1.0m, Q3 2025 1.0m
15 CENTERRA GOLD INC COM CGAU CGAU 497,402 $5.3m2.86% 2.86% ReducedShares held: Q4 2024 0, Q1 2025 0, Q2 2025 1.2m, Q3 2025 497.4k -730.5k -730,461 -59.5%
16 APPLIED THERAPEUTICS INC COM APLT APLT 7,799,687 $4.7m2.52% 2.52% UnchangedShares held: Q4 2024 5.8m, Q1 2025 7.8m, Q2 2025 7.8m, Q3 2025 7.8m
17 ALTIMMUNE INC COM NEW ALT ALT 1,121,524 $4.2m2.27% 2.27% UnchangedShares held: Q4 2024 1.1m, Q1 2025 1.1m, Q2 2025 1.1m, Q3 2025 1.1m
18 PAN AMERN SILVER CORP COM PAAS PAAS 100,035 $3.9m2.08% 2.08% NewShares held: Q4 2024 0, Q1 2025 0, Q2 2025 0, Q3 2025 100.0k
19 ISHARES SILVER TR ISHARES SLV SLV 80,000 $3.4m1.82% 1.82% UnchangedShares held: Q4 2024 80.0k, Q1 2025 80.0k, Q2 2025 80.0k, Q3 2025 80.0k
20 ROYAL GOLD INC COM RGLD RGLD 9,000 $1.8m0.97% 0.97% UnchangedShares held: Q4 2024 7.5k, Q1 2025 7.5k, Q2 2025 9.0k, Q3 2025 9.0k
21 COEUR MNG INC COM NEW CDE CDE 96,132 $1.8m0.97% 0.97% UnchangedShares held: Q4 2024 0, Q1 2025 96.1k, Q2 2025 96.1k, Q3 2025 96.1k
22 ALAMOS GOLD INC NEW COM CL A AGI AGI 50,000 $1.7m0.93% 0.93% UnchangedShares held: Q4 2024 41.0k, Q1 2025 41.0k, Q2 2025 50.0k, Q3 2025 50.0k
23 TRIPLE FLAG PRECIOUS METAL COM TFPM TFPM 58,800 $1.7m0.92% 0.92% NewShares held: Q4 2024 0, Q1 2025 0, Q2 2025 0, Q3 2025 58.8k
24 VISA INC COM CL A V V 4,850 $1.7m0.89% 0.89% UnchangedShares held: Q4 2024 4.8k, Q1 2025 4.8k, Q2 2025 4.8k, Q3 2025 4.8k
25 PHILIP MORRIS INTL INC COM PM PM 10,000 $1.6m0.87% 0.87% UnchangedShares held: Q4 2024 10.0k, Q1 2025 10.0k, Q2 2025 10.0k, Q3 2025 10.0k
26 ISHARES TR US AER DEF ETF ITA ITA 7,650 $1.6m0.86% 0.86% UnchangedShares held: Q4 2024 7.7k, Q1 2025 7.7k, Q2 2025 7.7k, Q3 2025 7.7k
27 WHEATON PRECIOUS METALS CORP COM WPM WPM 12,500 $1.4m0.75% 0.75% UnchangedShares held: Q4 2024 12.5k, Q1 2025 12.5k, Q2 2025 12.5k, Q3 2025 12.5k
28 NORTHROP GRUMMAN CORP COM NOC NOC 2,165 $1.3m0.71% 0.71% UnchangedShares held: Q4 2024 2.2k, Q1 2025 2.2k, Q2 2025 2.2k, Q3 2025 2.2k
29 NEW PAC METALS CORP COM NEWP NEWP 485,000 $1.3m0.70% 0.70% UnchangedShares held: Q4 2024 485.0k, Q1 2025 485.0k, Q2 2025 485.0k, Q3 2025 485.0k
30 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $1.3m0.70% 0.70% UnchangedShares held: Q4 2024 13.0k, Q1 2025 13.0k, Q2 2025 13.0k, Q3 2025 13.0k
31 DIAGEO PLC SPON ADR NEW DEO DEO 6,750 $644.2k0.35% 0.35% UnchangedShares held: Q4 2024 6.8k, Q1 2025 6.8k, Q2 2025 6.8k, Q3 2025 6.8k
32 DAKOTA GOLD CORP COM DC DC 122,921 $559.3k0.30% 0.30% NewShares held: Q4 2024 0, Q1 2025 0, Q2 2025 0, Q3 2025 122.9k
33 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 260,470 $536.6k0.29% 0.29% UnchangedShares held: Q4 2024 260.5k, Q1 2025 260.5k, Q2 2025 260.5k, Q3 2025 260.5k
34 HOOKIPA PHARMA INC COM COM 498,625 $461.2k0.25% 0.25% UnchangedShares held: Q4 2024 498.6k, Q1 2025 498.6k, Q2 2025 498.6k, Q3 2025 498.6k
35 ORCHESTRA BIOMED HLDGS INC COM OBIO OBIO 455,128 $421.2k0.23% 0.23% UnchangedShares held: Q4 2024 0, Q1 2025 0, Q2 2025 455.1k, Q3 2025 455.1k
36 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 62,689 $331.0k0.18% 0.18% UnchangedShares held: Q4 2024 0, Q1 2025 0, Q2 2025 62.7k, Q3 2025 62.7k
37 CARDIOL THERAPEUTICS INC COM CL A CRDL CRDL 100,000 $107.0k0.06% 0.06% UnchangedShares held: Q4 2024 100.0k, Q1 2025 100.0k, Q2 2025 100.0k, Q3 2025 100.0k
38 Orgenesis, Inc. COM COM 50,623 $50.6k0.03% 0.03% UnchangedShares held: Q4 2024 50.6k, Q1 2025 50.6k, Q2 2025 50.6k, Q3 2025 50.6k

Sold out since Q2 2025

SecurityTickerShares held beforeValue then
SKEENA RES LTD NEW SKE SKE 295,400 $4.7m295.4k shares
MAG SILVER CORP MAG MAG 170,000 $3.6m170.0k shares
VERONA PHARMA PLC VRNA VRNA 7,049 $666.7k7.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08